Skoog G, Cars O, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P, Erntell M STRAMA, Swedish Institute for Infectious.

Slides:



Advertisements
Similar presentations
European Centre for Disease Prevention and Control
Advertisements

Antibiotic policy to prevent resistance development Inga Odenholt Associate professor Department of Infectious Diseases, Malmö Lund University, Sweden.
The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.
Introduction to Antibiotics 1 st yr( Respiratory block) Prof. Azza Elmedany.
When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.
+ A Vitamin T Overdose? : An audit of piperacillin/ tazobactam use at Royal Perth Hospital Amelia Davis and Matthew Hanson Contributors: Dr Susan Benson,
Judicious Antibiotic Use in Developing Countries Global Missions Health Conference Louisville, KY Nov. 9, 2012 Ron Herman, Ph.D.
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
Information for Action Point Prevalence Survey of Healthcare associated infection and antimicrobial use 26 th June 2012 Dafydd Williams.
QUESTIONS AND ANSWERS. A patient is admitted to the surveillance specialty with a catheter in situ Are they included in CAUTI surveillance?
Use of antibiotics. Antibiotic use Antimicrobials are the 2 nd most common drugs prescribed by office based physicians In USA1992: 110 million oral antimicrobial.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student under Nephrology Division under the supervision and administration.
Drug and Therapeutics Committee Session 11. Drug Use Evaluation.
Antibiotic Prescribing Practices of Primary Care Prescribers for Acute Respiratory Tract Infections and Diarrhoea in New Delhi, India Anita Kotwani 1,
TRANSLATING VISITS INTO PATIENTS USING AMBULATORY VISIT DATA (Hypertensive patient case study) by Esther Hing, M.P.H. and Julia Holmes, Ph.D U.S. DEPARTMENT.
Improving Antibiotic use through a Nationwide Decentralized Project – A Nine-Year Experience Cars O, Stålsby Lundborg C, Mölstad S Swedish Strategic Programme.
Point Prevalence Survey of Hospital- Acquired Infections & Antimicrobial Use in Ireland PPS Data Collector Training April 2012 Background & Introduction.
Erntell M, Skoog G, Cars O, Eriksson M, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P. STRAMA, Swedish Institute.
Introduction to Antibiotics Prof. Azza ELMedany Pharmacology Department.
A parent brings her two year old son to your office because of a chief complaint of fussiness and tugging at his right ear for the past two days. He.
Medications for the Treatment of Infections. Antibiotic vs. Antibacterial Used interchangeably Origin of antibiotic includes any antimicrobial agent Antibacterial.
Incidence of hospitalisations in both groups Incidence of documented infections Abstract Problem statement: Patients on cancer chemotherapy are at substantial.
Swedres 2005 Swedres 2005 Figures and tables. Swedres 2005 Table Total use of antibacterial drugs for systemic use in Sveden , DDD/1000/day.
CLINICAL PHARMACOLOGY OF ANTIBACTERIAL AGENTS. Actions of antibacterial drugs on bacterial cells.
Introduction to Antibiotics Prof. Mohammad Alhumayyd Pharmacology Department.
ANTIBIOTICS.
Cheryl Meddles-Torres, DNP, RN, FNP-C Shuang Hu
Antimicrobials - Quinolones & Fluoroquinolones Antimicrobials - Quinolones & Fluoroquinolones Pharmacology -1 DSX 215 DSX 215 Dr/ Abdulaziz Saeedan Pharmacy.
ANTIBIOTIC USE IN PATIENTS WITH FEVER OF UNKNOWN ORIGIN (FUO) AT PANTI RAPIH HOSPITAL YOGYAKARTA-INDONESIA Hartayu T 1, Asdie HAH 2, Suryawati S 3 1 Faculty.
Skoog G, Cars O, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P, Erntell M. STRAMA, Swedish Institute for Infectious.
Introduction to Antibiotics 1 st yr( Respiratory block) Prof. Azza Elmedany.
Antibiotic utilization in general medical units in a tertiary care institution Fernando GVMC, Ratnasekera IU, Perera MSD, Wanigatunge CA.
Harm from Invasive Devices Dr. Eleri Davies, Faculty Lead HCAI.
An Audit to Determine if Prescribers are Reviewing Antimicrobial Prescriptions Hours After Initiation. Natalie Holman, Emma Cramp, Joy Baruah Hinchingbrooke.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 07- Penicillins.
Northern Dimension Antibiotic Resistance Study NoDARS Prof Jaana Vuopio, M.D., Ph.D., PAC 11 side-event, 19 November 2015, Berlin, Germany.
The AHRQ Safety Program for Improving Antibiotic Use
Antibiotic use and bacterial complications following upper respiratory tract infections: a population based study.
Antibiotics: handle with care!
Co-amoxiclav prescribing: York House Medical Practice
Antibiotics: handle with care!
Figure 1. Rate of antimicrobial resistance in S. pneumoniae
Use of antibiotics.
Figure 1. Algorithm for classifying patients with hospital-acquired pneumonia according to the Consensus Statement of the American Thoracic Society. Adapted.
The AHRQ Safety Program for Improving Antibiotic Use
Antibiotics: Handle with care!
Networks of hospitals: building a common strategy for HAI prevention and control and antimicrobial policy Tomasz Ozorowski, M.D. University of Medical.
The AHRQ Safety Program for Improving Antibiotic Use
Bacteraemia in Buckinghamshire Healthcare NHS Trust
Angelica Abad, Rachel Trengrove and Naomi Fleming Abstract 181
Danijela Daus-Šebeđak
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Hospital Antibiotic Stewardship Programs
Jessina C. McGregor, PhD; Miriam R. Elman, MPH; David T
Antibiotics, prescribed for outpatients in Sweden (ATC group J01 Excluding methenamine), DDD/1000/day,
GLOBAL POINT PREVALENCE SURVEY OF ANTIMICROBIAL CONSUMPTION AND RESISTANCE (GLOBAL-PPS): RESULTS OF ANTIMICROBIAL PRESCRIBING IN INDIA Dr. Sanjeev K Singh.
Improving Antibiotic use through a Nationwide Decentralized Project –
Presentation Title 36pt Arial Bold
Swedres 2007 Figures and tables Swedres 2007.
Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription  B. Maraha, M. Bonten, H. Fiolet,
B. Huttner, S. Harbarth, D. Nathwani 
Antibiotic Resistance
Prof. Mohammad Alhumayyd Pharmacology Department
Impact of Microbial Culture Analysis and Prophylactic use of Antibiotics in Acute Severe Pancreatitis Jagadish babu Dasari, Cristiano Ialongo, Aruna Chandranath.
Tony Crockford & Muhammad Sartaj.
INFECTIOUS DISEASES CLERKSHIP –
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Endocarditis is an inflammation of the endocardium, the membrane lining the chambers of the heart and covering the cusps of the heart valves. Infective.
AHRQ Safety Program for Improving Antibiotic Use
Presentation transcript:

Skoog G, Cars O, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P, Erntell M STRAMA, Swedish Institute for Infectious Disease Control, S Solna, Sweden POINT PREVALENCE STUDY OF ANTIBIOTIC USE IN SWEDISH HOSPITALS - PROPHYLAXIS IN ADULTS Introduction and purpose Data revealing antibiotic consumption and prescription patterns related to diagnose at the patient level is essential in finding ways to optimize antibiotic use in the hospital setting. Data are presented on the prophylactic use of antimicrobials from the first nation wide point prevalence study, PPS, performed in Sweden. Method A study physician visited each participating hospital ward. Data were collected for all hospitalized patients according to medical records. Prophylaxis was defined as peri-operative (single dose, 24 hours, >24 hours) and medical prophylaxis. Medical prophylaxis included therapy reasons like e.g. immunosuppression, HIV and recurrent UTI. The indication for prophylaxis was further defined by 19 pre-defined diagnosis groups. Results 54 hospitals participated in the study adult patients (4 117 recorded therapies) out of admitted patients were treated with antimicrobial agents. 783 (19%) of the therapies were given as prophylaxis. Medical prophylaxis: 199 therapies (212 antibiotics) 62% of the therapies were related to immunosuppression Peri-operative prophylaxis: 584 therapies (668 antibiotics) 44% were administred for >24 hours Duration of peri-operative prophylaxis Conclusions Peri-operative prophylaxis was long, 44% was >24 hours. 50% of all peri-operative prophylaxis (DDD) was isoxazolyl pc. Cephalosporins, fluoroquinolones and imidazoles were the most frequently used antibiotics in peri-operative prophylaxis. The same antibiotics are used in both prophylaxis and in therapy. Abstract POINT PREVALENCE STUDY OF ANTIBIOTIC USE IN SWEDISH HOSPITALS – PROPHYLAXIS IN ADULTS Skoog G, Cars O, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P, Erntell M. STRAMA, Swedish Institute for Infectious Disease Control, S Stockholm, Sweden Objectives: The objective of the study was to introduce a nation wide survey system for frequent assessment of the use of antimicrobial agents in relation to diagnosis. Using a web-based reporting system the STRAMA- groups have performed the first point prevalence study, PPS. Method: A nation wide PPS was performed within a two-week period in November A study physician visited each participating hospital ward. 19 pre-defined diagnosis groups (reason for prophylaxis) were used. The protocol was designed to present demographic data as well as the amounts and indications for antimicrobial agents against bacteria and fungi. Prophylaxis was defined as peri-operative and medical prophylaxis. Medical prophylaxis included therapy reasons like e.g. immunosuppression, HIV and recurrent UTI. Results: 54 hospitals participated in the study. 3,912 adult patients (4,117 recorded therapies) out of 12,623 admitted were treated with antimicrobial agents. 783 (19%) of the therapies were given as prophylaxis. 584 therapies (668 antibiotics) were given as peri-operative prophylaxis and 199 (212) as medical prophylaxis. The distribution of diagnosis groups for peri-operative prophylaxis was; bone and joint 211 (36%), cardiovascular system 65 (11%), lower gastrointestinal tract 57 (10%) and genital infections 55 (9%). Antibiotics given, in percent DDD, were; beta-lactamase resistant penicillins 51%, cephalosporins 19%, quinolones 6% and imidazole derivatives 5%. 90% of the peri-operative prophylaxis was given within the surgical specialities (gynaecology, surgical speciality, orthopaedics, urology and ENT). In 44% an antibiotic was prescribed for more than 24 hours. The distribution of diagnosis groups for medical prophylaxis was; mouth and throat 31 (16%), pulmonary infections 31 (16%), primary septicaemia 23 (12%), lower urinary tract 16 (8%) and lower gastrointestinal tract 15 (8%). Antibiotics given, in percent DDD, were; quinolones 22%, beta-lactamase resistant penicillins 15%, triazole derivatives 15%, cephalosporins 12% and co-trimoxazole 12%. Conlusions: Peri-operative surgical prophylaxis was too long, 44% was prescribed for more than 24 hours. The percentage of antibiotics that was given as more than one dose varied between 32% and 89% with the highest figure noted for prophylaxis in bone and joint surgery. Diagnosis groups Central nervous system Ophthalmic infections Mouth and throat Upper respiratory tract Bronchitis Pulmonary infections Cardiovascular system Upper gastrointestinal tract Lower gastrointestinal tract Infectious gastrointestinal diseases Liver/bile duct/pancreas/spleen Skin and soft tissue Bone and joint Lower urinary tract infection Upper urinary tract infection Genital infections Septicaemia, primary Un-specified indication, fever Indication unclear